ABBV
insider transactionsAbbVie Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
1.1K sh
Own +44%
-
Grant·A
Director
$0
1.1K sh
Own +44%
-
Grant·A
Director
$0
1.1K sh
Own +7%
-
Grant·A
Director
$0
1.1K sh
Own +4%
-
Grant·A
Director
$0
1.1K sh
Own +6%
-
Grant·A
Director
$0
1.1K sh
Own +8%
-
Grant·A
Director
$0
1.1K sh
Own +1%
-
Grant·A
Director
$0
1.1K sh
Own +4%
-
Grant·A
Director
$0
1.1K sh
Own +93%
-
Grant·A
Director
$0
1.1K sh
Own +2%
-
Grant·A
Director
$0
1.1K sh
Own +3%
-
Grant·A
Director
$19.7K
2.4K sh · $8.07
Own +1%
-
Grant·A
Director
$0
5.1K sh
Own +16%
-
Grant·A
Director
$15.4K
71 sh · $217.49
Own +10%
-
Grant·A
Director
$7.6K
35 sh · $217.49
Own +0%
-
Grant·A
Director
$33.7K
155 sh · $217.49
Own +1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 8, 2026 | Susan E Quaggin | Grant A | 1.1K | $0 |
| May 8, 2026 | Jennifer L. Davis | Grant A | 1.1K | $0 |
| May 8, 2026 | Melody B Meyer | Grant A | 1.1K | $0 |
| May 8, 2026 | William H.L. Burnside | Grant A | 1.1K | $0 |
| May 8, 2026 | Brett J Hart | Grant A | 1.1K | $0 |
| May 8, 2026 | Rebecca B Roberts | Grant A | 1.1K | $0 |
| May 8, 2026 | Thomas C Freyman | Grant A | 1.1K | $0 |
| May 8, 2026 | Frederick H Waddell | Grant A | 1.1K | $0 |
| May 8, 2026 | Thomas J Falk | Grant A | 1.1K | $0 |
| May 8, 2026 | Edward J Rapp | Grant A | 1.1K | $0 |
| May 8, 2026 | Roxanne S Austin | Grant A | 1.1K | $0 |
| Apr 1, 2026 | Roxanne S Austin | Grant A | 2.4K | $19.7K |
| Apr 1, 2026 | Roxanne S Austin | Grant A | 5.1K | $0 |
| Mar 31, 2026 | Susan E Quaggin | Grant A | 71 | $15.4K |
| Mar 31, 2026 | Robert J Alpern | Grant A | 35 | $7.6K |
| Mar 31, 2026 | Edward J Rapp | Grant A | 155 | $33.7K |
About ABBV insider trading
This page tracks insider transactions for AbbVie Inc. (ABBV) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.